FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988985578> ?p ?o ?g. }

• W1988985578 endingPage "1135" @default.
• W1988985578 startingPage "1129" @default.
• W1988985578 abstract "Colesevelam hydrochloride (colesevelam) lowers low-density lipoprotein (LDL) cholesterol and glycated hemoglobin in patients with type 2 diabetes mellitus. The present study examined the effects of colesevelam treatment in nondiabetic men with metabolic syndrome. Twenty men completed the study, which consisted of two 8-week phases of treatment with colesevelam (3.75 g/day) or placebo and a 6-week washout between study phases. Of the 20 men, 17 took statins throughout. The fasting plasma LDL cholesterol, triglyceride, glucose, and glycated hemoglobin levels were measured in the last 2 weeks of each study phase. Nonesterified fatty acids and 3-hydroxybutyrate, insulin, and glucose were measured hourly for 5 hours during fasting and during an extended glucose tolerance test. The colesevelam treatment reduced LDL cholesterol from 96 ± 28 mg/dl to 78 ± 32 mg/dl (p <0.006) and non–high-density lipoprotein cholesterol by 8.2% (p = 0.07). Triglycerides increased by 17% (p <0.02). The fasting plasma glucose was reduced by 5 mg/dl (p <0.03), and glycated hemoglobin remained unchanged by colesevelam. No significant treatment changes were noted for the 2-hour glucose test or insulin sensitivity. The fasting nonesterified fatty acid level was significantly reduced with treatment but the 3-hydroxybutyrate level was unchanged. Insulin-mediated suppression of nonesterified fatty acids during extended glucose tolerance test was significantly less effective during treatment than during placebo. In conclusion, colesevelam significantly reduced the LDL cholesterol levels, even though the baseline LDL cholesterol level was low owing to statin treatment. The fasting and postprandial blood glucose level but not the glycated hemoglobin level was lowered by colesevelam therapy. The effect on fasting glucose was unrelated to the changes in insulin resistance or fatty acid oxidation. Finally, an increase in triglycerides with colesevelam therapy might have been related to a lesser suppression of nonesterified fatty acids levels in the postprandial state. Colesevelam hydrochloride (colesevelam) lowers low-density lipoprotein (LDL) cholesterol and glycated hemoglobin in patients with type 2 diabetes mellitus. The present study examined the effects of colesevelam treatment in nondiabetic men with metabolic syndrome. Twenty men completed the study, which consisted of two 8-week phases of treatment with colesevelam (3.75 g/day) or placebo and a 6-week washout between study phases. Of the 20 men, 17 took statins throughout. The fasting plasma LDL cholesterol, triglyceride, glucose, and glycated hemoglobin levels were measured in the last 2 weeks of each study phase. Nonesterified fatty acids and 3-hydroxybutyrate, insulin, and glucose were measured hourly for 5 hours during fasting and during an extended glucose tolerance test. The colesevelam treatment reduced LDL cholesterol from 96 ± 28 mg/dl to 78 ± 32 mg/dl (p <0.006) and non–high-density lipoprotein cholesterol by 8.2% (p = 0.07). Triglycerides increased by 17% (p <0.02). The fasting plasma glucose was reduced by 5 mg/dl (p <0.03), and glycated hemoglobin remained unchanged by colesevelam. No significant treatment changes were noted for the 2-hour glucose test or insulin sensitivity. The fasting nonesterified fatty acid level was significantly reduced with treatment but the 3-hydroxybutyrate level was unchanged. Insulin-mediated suppression of nonesterified fatty acids during extended glucose tolerance test was significantly less effective during treatment than during placebo. In conclusion, colesevelam significantly reduced the LDL cholesterol levels, even though the baseline LDL cholesterol level was low owing to statin treatment. The fasting and postprandial blood glucose level but not the glycated hemoglobin level was lowered by colesevelam therapy. The effect on fasting glucose was unrelated to the changes in insulin resistance or fatty acid oxidation. Finally, an increase in triglycerides with colesevelam therapy might have been related to a lesser suppression of nonesterified fatty acids levels in the postprandial state." @default.
• W1988985578 created "2016-06-24" @default.
• W1988985578 creator A5056794714 @default.
• W1988985578 creator A5060416870 @default.
• W1988985578 creator A5090506611 @default.
• W1988985578 date "2011-10-01" @default.
• W1988985578 modified "2023-10-15" @default.
• W1988985578 title "Effect of Colesevelam Hydrochloride on Glycemia and Insulin Sensitivity in Men With the Metabolic Syndrome" @default.
• W1988985578 cites W1963966870 @default.
• W1988985578 cites W1968010896 @default.
• W1988985578 cites W1969550954 @default.
• W1988985578 cites W1971627211 @default.
• W1988985578 cites W1977208802 @default.
• W1988985578 cites W1980943448 @default.
• W1988985578 cites W2018104197 @default.
• W1988985578 cites W2033720203 @default.
• W1988985578 cites W2042129134 @default.
• W1988985578 cites W2046189497 @default.
• W1988985578 cites W2048837894 @default.
• W1988985578 cites W2058778081 @default.
• W1988985578 cites W2066062635 @default.
• W1988985578 cites W2067635119 @default.
• W1988985578 cites W2077241694 @default.
• W1988985578 cites W2086279639 @default.
• W1988985578 cites W2114027342 @default.
• W1988985578 cites W2115696651 @default.
• W1988985578 cites W2123289485 @default.
• W1988985578 cites W2127277443 @default.
• W1988985578 cites W2130047797 @default.
• W1988985578 cites W2138109132 @default.
• W1988985578 cites W2157454916 @default.
• W1988985578 cites W2331959986 @default.
• W1988985578 cites W4214663222 @default.
• W1988985578 doi "https://doi.org/10.1016/j.amjcard.2011.06.011" @default.
• W1988985578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21813109" @default.
• W1988985578 hasPublicationYear "2011" @default.
• W1988985578 type Work @default.
• W1988985578 sameAs 1988985578 @default.
• W1988985578 citedByCount "23" @default.
• W1988985578 countsByYear W19889855782012 @default.
• W1988985578 countsByYear W19889855782013 @default.
• W1988985578 countsByYear W19889855782014 @default.
• W1988985578 countsByYear W19889855782015 @default.
• W1988985578 countsByYear W19889855782016 @default.
• W1988985578 countsByYear W19889855782017 @default.
• W1988985578 countsByYear W19889855782019 @default.
• W1988985578 countsByYear W19889855782021 @default.
• W1988985578 countsByYear W19889855782022 @default.
• W1988985578 countsByYear W19889855782023 @default.
• W1988985578 crossrefType "journal-article" @default.
• W1988985578 hasAuthorship W1988985578A5056794714 @default.
• W1988985578 hasAuthorship W1988985578A5060416870 @default.
• W1988985578 hasAuthorship W1988985578A5090506611 @default.
• W1988985578 hasConcept C126322002 @default.
• W1988985578 hasConcept C134018914 @default.
• W1988985578 hasConcept C2777180221 @default.
• W1988985578 hasConcept C2777538456 @default.
• W1988985578 hasConcept C2778163477 @default.
• W1988985578 hasConcept C2778199505 @default.
• W1988985578 hasConcept C2778913445 @default.
• W1988985578 hasConcept C2779306644 @default.
• W1988985578 hasConcept C555293320 @default.
• W1988985578 hasConcept C71924100 @default.
• W1988985578 hasConceptScore W1988985578C126322002 @default.
• W1988985578 hasConceptScore W1988985578C134018914 @default.
• W1988985578 hasConceptScore W1988985578C2777180221 @default.
• W1988985578 hasConceptScore W1988985578C2777538456 @default.
• W1988985578 hasConceptScore W1988985578C2778163477 @default.
• W1988985578 hasConceptScore W1988985578C2778199505 @default.
• W1988985578 hasConceptScore W1988985578C2778913445 @default.
• W1988985578 hasConceptScore W1988985578C2779306644 @default.
• W1988985578 hasConceptScore W1988985578C555293320 @default.
• W1988985578 hasConceptScore W1988985578C71924100 @default.
• W1988985578 hasIssue "8" @default.
• W1988985578 hasLocation W19889855781 @default.
• W1988985578 hasOpenAccess W1988985578 @default.
• W1988985578 hasPrimaryLocation W19889855781 @default.
• W1988985578 hasRelatedWork W2010624657 @default.
• W1988985578 hasRelatedWork W2041359242 @default.
• W1988985578 hasRelatedWork W2046582544 @default.
• W1988985578 hasRelatedWork W2094230156 @default.
• W1988985578 hasRelatedWork W2379081288 @default.
• W1988985578 hasRelatedWork W2755615146 @default.
• W1988985578 hasRelatedWork W2907131053 @default.
• W1988985578 hasRelatedWork W2940950084 @default.
• W1988985578 hasRelatedWork W4251780571 @default.
• W1988985578 hasRelatedWork W4291284026 @default.
• W1988985578 hasVolume "108" @default.
• W1988985578 isParatext "false" @default.
• W1988985578 isRetracted "false" @default.
• W1988985578 magId "1988985578" @default.
• W1988985578 workType "article" @default.